NCT05847881

Brief Summary

The purpose of this study is to introduce and test the usefulness of a reflective process meant to empower people with chronic pain and help support participant's resiliency and thriving. The study team hypothesizes that:

  • Greater or equal to 80 percent of participants will report that the intervention was relatively easy to understand after orientation, low burden, potentially effective, and will have completed at least 2 of the 3 reflective tools.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable chronic-pain

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

April 25, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2023

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

October 23, 2024

Completed
Last Updated

October 23, 2024

Status Verified

October 1, 2024

Enrollment Period

3 months

First QC Date

April 25, 2023

Results QC Date

July 29, 2024

Last Update Submit

October 2, 2024

Conditions

Keywords

Positive psychology intervention

Outcome Measures

Primary Outcomes (1)

  • Participants Engaged in the Interventions

    The timepoints were as follows: consent and survey (T1), Kick-off Meeting (T2), Workshop (T3), and Exit Interview (T4). Participants had to attend the Kick-off Meeting (T2) to be considered engaged in the intervention. Participants who did not attend the Kick-off Meeting (T2) were withdrawn. Participants who did not attend the Workshop (T3) could still attend the Exit Interview (T4).

    Baseline (T1) to Exit Interview (T4), up to 68 days

Secondary Outcomes (2)

  • Patient Global Impression of Change (PGIC) at T4 Exit Interview

    at T4 Exit Interview, up to 68 days

  • Change in Pain Interference Based on the Patient-Reported Outcomes Measurement Information System (PROMIS) 29 Version 2.0 Between Baseline (t1) and Approximately 68 Days (t4 Exit Interview)

    Up to 68 days

Study Arms (1)

Reflective process group

EXPERIMENTAL
Behavioral: Self-guided at home activities

Interventions

After the kick-off meeting participants will complete the cultural probe kit for 3 weeks. This kit is a design research tool, to prompt participants to document, map, journal, and reflect on various aspects of daily lives. Following this, participants will attend a facilitated workshop and then complete the next at-home kits.

Reflective process group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Persistent or recurrent pain lasting longer than 3 months
  • Able to read and write English

You may not qualify if:

  • Cancer (History of any bone-related cancer or cancer that metastasized to the bone; Currently in treatment for any cancer or plan to start cancer treatment in the next 12 months; History of any cancer treatment in the last 24 months)
  • Active substance abuse
  • Uncontrolled depression or psychosis
  • Visual or hearing difficulties that would preclude participation
  • Individuals started receiving disability or compensation within the past year, or currently involved in litigation
  • Current/planned (in the next 2 years) enrollment in another study of a device or investigational drug that would interfere with this study, this may include participation in a blinded trial.
  • Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators. This would include but not be limited to severe psychiatric disorders, active suicidal ideations or history of suicide attempts, and an uncontrolled drug and/or alcohol addiction)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Afton L. Hassett, PsyD
Organization
Back & Pain Center Clinical Research

Study Officials

  • Hannah Smotrich

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Art and Design

Study Record Dates

First Submitted

April 25, 2023

First Posted

May 8, 2023

Study Start

April 25, 2023

Primary Completion

July 25, 2023

Study Completion

July 25, 2023

Last Updated

October 23, 2024

Results First Posted

October 23, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations